Holdings of Eagle Health Investments LP
23 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 66.1 % of the equity sleeve
Sector breakdown
- Health care 37.5 %
- Unattributed 62.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 79.7 %
- NL 13.0 %
- DK 4.6 %
- GB 2.7 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 20 | 340.8M $ | 79.67 % |
| 2 | NL | 1 | 55.7M $ | 13.03 % |
| 3 | DK | 1 | 19.8M $ | 4.63 % |
| 4 | GB | 1 | 11.4M $ | 2.66 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Argenx SE | 76,336 | 55.7M $ | |
| 2 | Insmed Inc | 224,271 | 36.7M $ | |
| 3 | Guardant Health Inc | 310,281 | 28.7M $ | |
| 4 | BioMarin Pharmaceutical Inc | 505,809 | 28.6M $ | |
| 5 | Natera Inc | 121,877 | 24.4M $ | |
| 6 | Scholar Rock Holding Corp | 494,019 | 24.3M $ | |
| 7 | Illumina Inc | 187,413 | 23.1M $ | |
| 8 | Terns Pharmaceuticals Inc | 412,497 | 21.7M $ | |
| 9 | Bridgebio Pharma Inc | 267,031 | 19.8M $ | |
| 10 | Ascendis Pharma A/S | 86,650 | 19.8M $ | |
| 11 | Protagonist Therapeutics Inc | 179,322 | 18.9M $ | |
| 12 | Ultragenyx Pharmaceutical Inc | 884,121 | 18.5M $ | |
| 13 | Boston Scientific Corp | 293,152 | 18.4M $ | |
| 14 | Fortrea Holdings Inc | 1,307,560 | 12.3M $ | |
| 15 | Kymera Therapeutics Inc | 145,816 | 12.1M $ | |
| 16 | PROCEPT BIOROBOTICS CORP | 483,815 | 12.1M $ | |
| 17 | Revolution Medicines Inc | 119,464 | 11.6M $ | |
| 18 | Tempus AI Inc | 256,269 | 11.6M $ | |
| 19 | Compass Pathways plc | 2,060,427 | 11.4M $ | |
| 20 | CENTESSA PHARMACEUTICALS PLC | 214,291 | 8.5M $ | |
| 21 | AtaiBeckley Inc | 1,709,359 | 6.1M $ | |
| 22 | Intuitive Surgical Inc | 4,390 | 2M $ | |
| 23 | Immunocore Holdings PLC | 46,300 | 1.4M $ |